There are no significant Insider Shareholders in Compass Therapeutics as of December 12, 2025.
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Thomas J. Schuetz | Chief Executive Officer | 6,436,800 | 18 Nov, 2025 |
| Vered Bisker-Leib | Chief Executive Officer | 3,124,426 | 09 Feb, 2024 |
| Miranda Jayne Toledano | 1,791,549 | 29 Jun, 2021 | |
| Barry Shin | Cfo | 400,000 | 10 Dec, 2024 |
| Neil Lerner | Chief Accounting Officer | 320,000 | 08 Apr, 2025 |
| Jonathan Anderman | Gen Counsel & Corporate Sec | 21,000 | 08 Apr, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 16 Nov, 2025 | Thomas J. Schuetz | Common Stock | D | 44,025 | $4.83 | 6,436,800 | D | F |
| 27 May, 2025 | Thomas J. Schuetz | Common Stock | A | 10,000 | $2.11 | 6,480,825 | D | P |
| 09 Apr, 2025 | Advisors Llc Orbimed | Common Stock | D | 3,571,428 | $1.59 | 0 | I | S |
| 09 Apr, 2025 | Carl L Gordon | - | - | 0 | I | |||
| 09 Apr, 2025 | Carl L Gordon | Common Stock | D | 3,571,428 | $1.59 | 0 | I | S |
| 07 Apr, 2025 | Jonathan Anderman | - | - | 21,000 | D | |||
| 07 Apr, 2025 | Neil Lerner | Common Stock | A | 20,000 | $1.42 | 320,000 | D | P |
| 07 Apr, 2025 | Jonathan Anderman | Common Stock | A | 20,000 | $1.54 | 21,000 | D | P |
| 08 Feb, 2025 | Thomas J. Schuetz | Common Stock | D | 41,687 | $3.50 | 6,470,825 | D | F |
| 09 Jan, 2025 | Thomas J. Schuetz | Common Stock | D | 58,054 | $1.86 | 6,512,512 | D | F |
| 09 Dec, 2024 | Barry Shin | Common Stock | A | 400,000 | $1.65 | 400,000 | D | A |
| 09 Dec, 2024 | Barry Shin | - | - | 400,000 | D | |||
| 08 Feb, 2024 | Vered Bisker-Leib | Common Stock | D | 49,198 | $1.45 | 3,124,426 | D | F |
| 08 Feb, 2024 | Thomas J. Schuetz | Common Stock | D | 44,782 | $1.45 | 6,570,566 | D | F |
| 09 Jan, 2024 | Thomas J. Schuetz | Common Stock | A | 637,500 | $1.93 | 6,615,348 | D | A |
| 09 Jan, 2024 | Thomas J. Schuetz | - | - | 6,615,348 | D | |||
| 09 Jan, 2024 | Vered Bisker-Leib | Common Stock | A | 1,753,125 | $1.93 | 3,173,624 | D | A |
| 17 Nov, 2023 | Vered Bisker-Leib | Common Stock | D | 64,415 | $1.50 | 1,420,499 | D | F |
| 17 Nov, 2023 | Thomas J. Schuetz | Common Stock | D | 44,025 | $1.50 | 5,977,848 | D | F |
| 10 Mar, 2023 | Thomas J. Schuetz | Common Stock | A | 10,000 | $3.37 | 6,021,873 | D | P |